Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial

Stereotactic body radiotherapy (SBRT) can delay escalation to systemic treatment in men with oligometastatic prostate cancer (PCa). However, large, prospective studies are still required to evaluate the efficacy of this approach in different patient groups. This is the interim analysis of a prospect...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2020-01, Vol.146 (1), p.161-168
Hauptverfasser:	Bowden, Patrick, See, Andrew W., Frydenberg, Mark, Haxhimolla, Hodo, Costello, Anthony J., Moon, Daniel, Ruljancich, Paul, Grummet, Jeremy, Crosthwaite, Alan, Pranavan, Ganes, Peters, Justin S., So, Kevin, Gwini, Stella M., McKenzie, Dean P., Nolan, Skye, Smyth, Lloyd M.L., Everitt, Craig
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Androgen Antagonists - therapeutic use androgen deprivation therapy Cancer Castration Clinical trials Dose Fractionation, Radiation Humans Lesions Male Medical research Metastasis Middle Aged Neoplasm Metastasis - radiotherapy oligometastases Patients Prospective Studies Prostate cancer Prostate-Specific Antigen - blood Prostatic Neoplasms - drug therapy Prostatic Neoplasms - pathology Prostatic Neoplasms - radiotherapy Radiation therapy Radiosurgery - methods stereotactic body radiotherapy Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!